Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank86
3Y CAGR+20.5%
5Y CAGR+22.2%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
+20.5%/yr
vs +23.6%/yr prior
5Y CAGR
+22.2%/yr
Consistent
Acceleration
-3.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $156.12M | -26.8% |
| 2024 | $213.39M | +16.3% |
| 2023 | $183.50M | +105.8% |
| 2022 | $89.18M | -9.0% |
| 2021 | $97.99M | +71.1% |
| 2020 | $57.27M | +37.1% |
| 2019 | $41.76M | +9.4% |
| 2018 | $38.19M | -2.6% |
| 2017 | $39.21M | +1.7% |
| 2016 | $38.56M | - |